# Ferrer Internacional S.A. clinical trials: 21 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 21 trials with Ferrer Internacional S.A. as lead sponsor, 1 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Ferrer Internacional S.A.: 21 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/ferrer-internacional-s-a

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 21
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 21 newest of 21, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| July 12, 2024 | NCT06499363 | Treprostinil in Newborns With Pulmonary Hypertension; a Non-Interventional Study to Collect Data on Drug Utilization, Safety, and... | Ferrer Internacional S.A. | Observational | Recruiting | Persistent Pulmonary Hypertension of Newborn | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06499363) |
| April 9, 2024 | NCT06355531 | A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP) | Ferrer Internacional S.A. | Phase 2 | Completed | Progressive Supranuclear Palsy | 241 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06355531) |
| May 19, 2023 | NCT05866926 | Study to Investigate the Long-term Safety of FAB122 in Patients With Amyotrophic Lateral Sclerosis | Ferrer Internacional S.A. | Phase 3 | Terminated | Amyotrophic Lateral Sclerosis | 201 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05866926) |
| October 10, 2022 | NCT05572996 | Inhaled Treprostinil Expanded Access Program in Pulmonary Hypertension Associated With Interstitial Lung Disease | Ferrer Internacional S.A. | Not applicable | Available | Pulmonary Hypertension, Interstitial Lung Disease, Combined Pulmonary Fibrosis and Emphysema | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05572996) |
| January 5, 2022 | NCT05178810 | Study to Investigate the Efficacy and Safety of FAB122 (Daily Oral Edaravone) in Patients With Amyotrophic Lateral Sclerosis | Ferrer Internacional S.A. | Phase 3 | Completed | Amyotrophic Lateral Sclerosis | 313 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05178810) |
| August 22, 2019 | NCT04065529 | Clinical Trial in Children Between 3 Months and 14 Years Old to Evaluate the Efficacy and Safety of Gelatin Tannate in the Treatment of... | Ferrer Internacional S.A. | Phase 3 | Completed | Diarrhea | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04065529) |
| September 28, 2016 | NCT02917291 | Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury | Ferrer Internacional S.A. | Phase 1/2 | Unknown | Acute Traumatic Spinal Cord Injury | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02917291) |
| June 7, 2016 | NCT02791958 | Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic... | Ferrer Internacional S.A. | Phase 2 | Unknown | Hypertension | 528 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02791958) |
| August 18, 2015 | NCT02525991 | Phase IV to Evaluate the Safety of Self-administered ADASUVE® in Agitated Patients Outside the Hospital Setting | Ferrer Internacional S.A. | Phase 4 | Completed | Agitation | 323 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02525991) |
| March 18, 2014 | NCT02090764 | Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo | Ferrer Internacional S.A. | Phase 3 | Completed | Impetigo | 412 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02090764) |
| July 20, 2012 | NCT01646580 | Safety Study of Ciclopirox Olamine Cream for Dermatomycoses in Children | Ferrer Internacional S.A. | Phase 4 | Terminated | Dermatomycoses | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01646580) |
| March 9, 2012 | NCT01549158 | Single Dose Study to Compare the Pharmacodynamics of Torasemide-PR 10 mg,Torasemide-IR 10 mg and Furosemide-IR 40 mg in Patients With... | Ferrer Internacional S.A. | Phase 4 | Terminated | Compensated Heart Failure | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01549158) |
| July 19, 2011 | NCT01397461 | Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo | Ferrer Internacional S.A. | Phase 3 | Completed | Impetigo | 465 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01397461) |
| May 30, 2011 | NCT01362218 | Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol | Ferrer Internacional S.A. | Phase 2 | Terminated | Elevated LDL Cholesterol | 107 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01362218) |
| June 15, 2010 | NCT01144286 | Arasertaconazole Nitrate Pessaries - Dose Finding Study for the Vulvovaginal Candidiasis (VVC) Treatment | Ferrer Internacional S.A. | Phase 2 | Completed | Vulvovaginal Candidiasis | 229 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01144286) |
| November 2, 2009 | NCT01005771 | Study to Assess the Efficacy and Safety of GF-001001-00 Cream in Secondarily-Infected Traumatic Lesions | Ferrer Internacional S.A. | Phase 2 | Completed | Secondarily Infected Traumatic Lesions | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01005771) |
| October 30, 2009 | NCT01005290 | A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Blood Pressure | Ferrer Internacional S.A. | Phase 2 | Terminated | Hypertension | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01005290) |
| October 30, 2009 | NCT01004705 | A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol | Ferrer Internacional S.A. | Phase 2 | Terminated | Elevated LDL Cholesterol | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01004705) |
| December 12, 2006 | NCT00409942 | Effect of a New Formulation of Torasemide (Prolonged Release)on Myocardial Fibrosis in Patients With Heart Failure. | Ferrer Internacional S.A. | Phase 4 | Completed | Congestive Heart Failure | 142 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00409942) |
| June 7, 2006 | NCT00334386 | Hypertension Study: Multinational Torasemide Trial in Mild to Moderate Hypertension. | Ferrer Internacional S.A. | Phase 4 | Completed | Hypertension | 388 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00334386) |
| May 31, 2006 | NCT00331890 | ICTUS Study: International Citicoline Trial on Acute Stroke | Ferrer Internacional S.A. | Phase 3 | Terminated | Acute Stroke, Cerebral Infarction | 2,298 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00331890) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1/2 | 1 |
| Phase 2 | 7 |
| Phase 3 | 6 |
| Phase 4 | 5 |
| Not applicable | 1 |
| Observational | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 10 |
| Terminated | 7 |
| Unknown | 2 |
| Available | 1 |
| Recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Hypertension | 3 |
| Hyperlipoproteinemia Type II | 2 |
| Candidiasis | 2 |
| Impetigo | 2 |
| Amyotrophic Lateral Sclerosis | 2 |
| Hypertension, Pulmonary | 1 |
| Lung Diseases, Interstitial | 1 |
| Emphysema | 1 |
| Dermatomycoses | 1 |
| Tinea | 1 |
| Heart Failure | 1 |
| Candidiasis, Vulvovaginal | 1 |
| Stroke | 1 |
| Cerebral Infarction | 1 |
| Ischemic Stroke | 1 |
| Spinal Cord Injuries | 1 |
| Psychomotor Agitation | 1 |
| Schizophrenia | 1 |
| Bipolar Disorder | 1 |
| Diarrhea | 1 |
| Gastroenteritis | 1 |
| Persistent Fetal Circulation Syndrome | 1 |
| Supranuclear Palsy, Progressive | 1 |
| Disease Progression | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Coffee shops in the United States](https://specstream.ai/data/businesses/coffee-shops/united-states)
- [Furniture wholesalers in the United States](https://specstream.ai/data/businesses/furniture-wholesalers/united-states)
- [Medical research institutes in the United States](https://specstream.ai/data/businesses/medical-research-institutes/united-states)
- [Remodeling contractors in the United States](https://specstream.ai/data/businesses/remodeling-contractors/united-states)
- [Welding companies in the United States](https://specstream.ai/data/businesses/welding-companies/united-states)
- [Business consulting firms in the United States](https://specstream.ai/data/businesses/business-consulting-firms/united-states)
